MabCure, Inc. (MBCI)


-0.01 (-96.67%)
Symbol MBCI
Price $0.0003
Beta 13.971
Volume Avg. 0.00M
Market Cap 0.644M
Shares () -
52 Week Range 2.0E-4-0.009
1y Target Est -
DCF Unlevered MBCI DCF ->
DCF Levered MBCI LDCF ->
ROE -127.05% Strong Sell
ROA -258.80% Strong Sell
Operating Margin -
Debt / Equity 6.74% Neutral
P/E -0.03 Neutral
P/B -


Consensus EPS

Upgrades & Downgrades

Mr. Jehu Thomas Degerold Hand
Other OTC

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.